Facebook tracking pixel
R47.01
ICD-10-CM
Expressive Aphasia

Understanding Expressive Aphasia, also known as Broca's Aphasia or Non-fluent Aphasia, is crucial for accurate clinical documentation and medical coding. This page provides healthcare professionals with information on diagnosing and documenting Expressive Aphasia, including symptoms, ICD-10 codes, and best practices for patient care. Learn about the challenges faced by individuals with Expressive Aphasia and effective communication strategies. Improve your understanding of this language disorder for improved patient outcomes and accurate healthcare records.

Also known as

Broca's Aphasia
Non-fluent Aphasia

Diagnosis Snapshot

Key Facts
  • Definition : Loss of ability to produce spoken or written language, with comprehension mostly intact.
  • Clinical Signs : Difficulty forming words and sentences, slow speech, effortful speech, writing difficulties.
  • Common Settings : Stroke rehabilitation, speech therapy clinics, neurology departments, skilled nursing facilities.

Related ICD-10 Code Ranges

Complete code families applicable to AAPC R47.01 Coding
F80.1

Expressive aphasia

Loss of ability to produce spoken or written language.

F80.81

Aphasia, mixed, with predominately expressive features

Combines expressive and receptive aphasia, primarily expressive.

R47.01

Dysphasia and aphasia

Includes difficulty understanding or producing language.

I69

Sequelae of cerebrovascular disease

Long-term effects of stroke, a common cause of aphasia.

Code-Specific Guidance

Decision Tree for

Follow this step-by-step guide to choose the correct ICD-10 code.

Is the aphasia expressive (difficulty producing speech)?

Code Comparison

Related Codes Comparison

When to use each related code

Description
Difficulty producing speech, but comprehension is mostly intact.
Impaired language comprehension and often nonsensical speech.
Severe impairment of both speech production and comprehension.

Documentation Best Practices

Documentation Checklist
  • Document impaired language expression.
  • Specify type of aphasia (Brocas, nonfluent).
  • Note language comprehension abilities.
  • Record severity and impact on function.
  • Include standardized aphasia assessment results.

Coding and Audit Risks

Common Risks
  • Code Specificity

    Coding expressive aphasia requires differentiating it from other aphasia types (e.g., receptive, global) for accurate reimbursement.

  • Documentation Clarity

    Insufficient clinical documentation to support the diagnosis of expressive aphasia can lead to coding errors and claim denials.

  • Laterality Coding

    Failing to document and code laterality (dominant vs. non-dominant hemisphere) can impact medical necessity reviews.

Mitigation Tips

Best Practices
  • Speech therapy: Focus on melodic intonation therapy.
  • Augmentative and alternative communication (AAC) devices.
  • Simplify language, use short sentences, be patient.
  • Encourage writing, drawing, gesturing for expression.
  • Group therapy for social interaction and peer support.

Clinical Decision Support

Checklist
  • Confirm impaired speech production, effortful speech documented
  • Check comprehension relatively intact per assessment
  • Verify presence of agrammatism, phonemic errors noted
  • Assess for co-occurring motor deficits, apraxia
  • Rule out other language disorders, dysarthria documented

Reimbursement and Quality Metrics

Impact Summary
  • E: Expressive Aphasia (Brocas Aphasia, Non-fluent Aphasia) Reimbursement and Quality Metrics Impact Summary
  • ICD-10 Coding: Accurate coding (e.g., I69.0) impacts MS-DRG assignment and reimbursement.
  • Quality Reporting: Aphasia severity influences functional communication measures and patient outcomes.
  • Rehabilitation Services: Therapy intensity and duration affect reimbursement and quality scores.
  • Medical Billing: Proper documentation of aphasia type and severity is crucial for appropriate billing.

Streamline Your Medical Coding

Let S10.AI help you select the most accurate ICD-10 codes. Our AI-powered assistant ensures compliance and reduces coding errors.

Frequently Asked Questions

Common Questions and Answers

Q: What are the most effective evidence-based treatment approaches for adults with expressive aphasia following stroke?

A: Several evidence-based treatment approaches have shown efficacy in improving language function for adults with expressive aphasia post-stroke. Constraint-Induced Language Therapy (CILT) encourages verbal communication by restricting compensatory strategies like gesturing. Melodic Intonation Therapy (MIT) utilizes melodic patterns to facilitate speech production, particularly beneficial for individuals with severe non-fluent aphasia. Script training, involving repeated practice of functional phrases and scripts, helps improve automatic speech in everyday situations. Furthermore, emerging research suggests the benefits of incorporating technology-assisted interventions, such as virtual reality and computer-based language programs, to enhance engagement and personalize treatment. Explore how integrating these approaches into a comprehensive rehabilitation plan can maximize functional outcomes for individuals with expressive aphasia. Consider implementing outcome measures, like the Western Aphasia Battery-Revised (WAB-R) or the Boston Naming Test (BNT), to track progress and tailor treatment accordingly.

Q: How can I differentiate between Broca's aphasia, transcortical motor aphasia, and global aphasia in my clinical practice?

A: Differentiating between Broca's aphasia, transcortical motor aphasia, and global aphasia requires careful assessment of spontaneous speech, repetition, and comprehension. In Broca's aphasia (also known as expressive aphasia or non-fluent aphasia), spontaneous speech is non-fluent, agrammatic, and effortful, while comprehension is relatively preserved. Repetition is typically impaired, but less severely than spontaneous speech. Transcortical motor aphasia shares similar features with Broca's aphasia, including non-fluent speech, but, crucially, repetition is relatively preserved. Global aphasia presents with severe impairments in all language modalities, including severely impaired spontaneous speech, comprehension, and repetition. Detailed assessment using standardized language batteries, such as the WAB-R, and observation of functional communication are essential for accurate diagnosis and tailored treatment planning. Learn more about specific assessment tasks that can help pinpoint the key distinguishing features of these aphasia subtypes.

Quick Tips

Practical Coding Tips
  • Code I69.0 for Expressive Aphasia
  • Use ICD-10 I69.0 for Brocas
  • Document language expression deficits
  • Check for co-occurring speech apraxia
  • Query physician for clarity if needed

Documentation Templates

Patient presents with symptoms consistent with Expressive Aphasia, also known as Broca's Aphasia or Non-fluent Aphasia.  The patient exhibits difficulty with speech production, characterized by telegraphic speech, agrammatism, and impaired articulation.  Word-finding difficulties (anomia) and labored speech are evident.  Comprehension remains relatively intact, although complex grammatical structures may pose a challenge.  The patient demonstrates frustration with communication difficulties.  Assessment includes evaluation of spontaneous speech, repetition, naming, and comprehension.  Differential diagnosis considers other communication disorders such as dysarthria, apraxia of speech, and other types of aphasia.  Etiology is likely related to a cerebrovascular accident impacting the Broca's area.  ICD-10 code I69.1, Aphasia following cerebrovascular accident, is the presumptive diagnosis pending further investigation.  Plan includes referral to speech-language pathology for comprehensive assessment and treatment focusing on improving verbal expression, utilizing strategies for communication, and providing patient and family education regarding aphasia management.  Prognosis will be determined based on response to therapy and underlying neurological recovery.  Further diagnostic testing, such as neuroimaging (MRI or CT scan), may be considered to confirm the location and extent of the lesion.